Kidney cancer

• Health & Medicine

More than 2 million years of life are lost to cancer each year

Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK. However, the data also showed that thanks to innovation and research, we are making progress in beating cancer.   Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK. However, the data also showed that thanks to innovation and research, we are making progress in beating cancer.  

11 October 2023

• Science & Technology

Scientists find cells in centre of tumours are most likely to spread

The new findings shed light on how cancer cells found in different parts of a tumour behave differently. The new findings shed light on how cancer cells found in different parts of a tumour behave differently.

19 May 2021

• Health & Medicine

Kidney cancer drug gets initial ‘no’ for the NHS in England

A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England

17 February 2020

• Health & Medicine

Obese people outnumber smokers two to one

People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types. People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types.

3 July 2019

• Health & Medicine

Kidney and lung cancer drugs approved on the NHS in Scotland

One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland. One kidney cancer treatment and two lung cancer drugs have been recommended for use on the NHS in Scotland.

12 June 2019

• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials. Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

19 February 2019

• Health & Medicine

Recurring infections could lead to delayed bladder or kidney cancer diagnosis

Women with bladder or kidney cancer may lose out on a prompt diagnosis if they are already being regularly treated for recurring urinary tract infections (UTIs) Women with bladder or kidney cancer may lose out on a prompt diagnosis if they are already being regularly treated for recurring urinary tract infections (UTIs)

13 February 2019

• Health & Medicine

Clinical trial launches to develop breath test for multiple cancers

Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage. Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.

2 January 2019

• Health & Medicine

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England. People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

13 December 2018

• Health & Medicine

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer. The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

3 June 2018

• Science & Technology

Piecing together kidney cancer evolution

Our scientists have tracked the evolution of kidney cancers. Find out how this could help patients in the future. Our scientists have tracked the evolution of kidney cancers. Find out how this could help patients in the future.

12 April 2018